Literature DB >> 18539918

Intensive glycemic control in the ACCORD and ADVANCE trials.

Robert G Dluhy, Graham T McMahon.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18539918     DOI: 10.1056/NEJMe0804182

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  99 in total

Review 1.  Evidence, values, guidelines and rational decision-making.

Authors:  Bruce Barrett
Journal:  J Gen Intern Med       Date:  2011-10-05       Impact factor: 5.128

2.  Blood pressure control in type 2 diabetes mellitus.

Authors:  Tara I Chang; Alfred K Cheung; Glenn M Chertow
Journal:  Am J Kidney Dis       Date:  2010-09-25       Impact factor: 8.860

3.  Cost-effectiveness of an electronic medical record based clinical decision support system.

Authors:  Todd P Gilmer; Patrick J O'Connor; JoAnn M Sperl-Hillen; William A Rush; Paul E Johnson; Gerald H Amundson; Stephen E Asche; Heidi L Ekstrom
Journal:  Health Serv Res       Date:  2012-05-11       Impact factor: 3.402

4.  The hyperglycemic and hyperinsulinemic combo gives you diabetic kidney disease immediately. Focus on "Combined acute hyperglycemic and hyperinsulinemic clamp induced profibrotic and proinflammatory responses in the kidney".

Authors:  Seung Hyeok Han; Katalin Susztak
Journal:  Am J Physiol Cell Physiol       Date:  2013-12-11       Impact factor: 4.249

Review 5.  Molecular Mechanisms Underlying the Cardiovascular Benefits of SGLT2i and GLP-1RA.

Authors:  Dorrin Zarrin Khat; Mansoor Husain
Journal:  Curr Diab Rep       Date:  2018-06-09       Impact factor: 4.810

6.  Treatment of spontaneously hypertensive rats with rosiglitazone ameliorates cardiovascular pathophysiology via antioxidant mechanisms in the vasculature.

Authors:  Maria A Potenza; Sara Gagliardi; Leonarda De Benedictis; Addolorata Zigrino; Edy Tiravanti; Giuseppe Colantuono; Antonio Federici; Loredana Lorusso; Vincenzo Benagiano; Michael J Quon; Monica Montagnani
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-06-16       Impact factor: 4.310

7.  A multinational, observational study to investigate the efficacy, safety and tolerability of acarbose as add-on or monotherapy in a range of patients: the Gluco VIP study.

Authors:  Weiwei Zhang; Dongjun Kim; Elizabeth Philip; Zahid Miyan; Irina Barykina; Birgit Schmidt; Herbert Stein
Journal:  Clin Drug Investig       Date:  2013-04       Impact factor: 2.859

Review 8.  Coronary artery disease and diabetes mellitus.

Authors:  Doron Aronson; Elazer R Edelman
Journal:  Cardiol Clin       Date:  2014-06-10       Impact factor: 2.213

9.  Diabetes-Related Cognitive Decline, a Global Health Issue, and New Treatments Approaches.

Authors:  Vera Novak; Federico Gomez; Alexandre Campos Dias; Daniela A Pimentel; Freddy J Alfaro
Journal:  Int J Priv Health Inf Manag       Date:  2017 Jul-Dec

10.  Cardiovascular and autonomic phenotype of db/db diabetic mice.

Authors:  Danielle Senador; Keerthy Kanakamedala; Maria Claudia Irigoyen; Mariana Morris; Khalid M Elased
Journal:  Exp Physiol       Date:  2009-02-13       Impact factor: 2.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.